# A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients with Acute Ischemic Stroke

> **NCT06700824** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Organ, Tissue, Regeneration, Repair and Replacement** · enrollment: 60 (estimated)

## Conditions studied

- Endovascular Thrombectomy
- Ischemic Cerebrovascular Accident

## Interventions

- **DEVICE:** OTR4132
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT06700824
- **Lead sponsor:** Organ, Tissue, Regeneration, Repair and Replacement
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06700824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06700824, "A Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients with Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06700824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*